Literature DB >> 30597027

Vaginal Microbiota and In Vitro Fertilization Outcomes: Development of a Simple Diagnostic Tool to Predict Patients at Risk of a Poor Reproductive Outcome.

Thor Haahr1,2, Peter Humaidan1,2, Helle Olesen Elbaek1,2, Birgit Alsbjerg1,2, Rita Jakubcionyte Laursen1,2, Kåre Rygaard3, Thor Bech Johannesen4, Paal Skytt Andersen4, Kim Lee Ng4, Jørgen Skov Jensen4.   

Abstract

BACKGROUND: Female reproductive tract microbiota may affect human reproduction. The current study considered whether a more detailed characterization of the vaginal microbiota could improve prediction of risk of poor reproductive outcome in patients undergoing in vitro fertilization (IVF).
METHODS: Vaginal samples from 120 patients undergoing IVF were sequenced using the V4 region of the 16S ribosomal RNA gene with clustering of Gardnerella vaginalis genomic clades. Abnormal vaginal microbiota was defined by microscopy and quantitative polymerase chain reaction (qPCR) for G. vaginalis and/or Atopobium vaginae above a threshold.
RESULTS: Three major community state types with abundance of Lactobacillus crispatus, Lactobacillus iners, and a diverse community type were identified, including 2 subtypes, characterized by a high abundance of L. crispatus and L. iners, respectively, but in combination with common diversity type operational taxonomic units. No significant association between community state type and the reproductive outcome could be demonstrated; however, abnormal vaginal microbiota by qPCR and a grouping based on high Shannon diversity index predicted the reproductive outcome equally well.
CONCLUSIONS: The predictive value of 16S ribosomal RNA gene sequencing was not superior to the simpler and less expensive qPCR diagnostic approach in predicting the risk of a poor reproductive outcome in patients undergoing IVF. CLINICAL TRIALS REGISTRATION: NCT02042352.
© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Vaginal microbiome; Vaginal microbiota; bacterial vaginosis; in vitro fertilization; infertility; pregnancy

Mesh:

Substances:

Year:  2019        PMID: 30597027     DOI: 10.1093/infdis/jiy744

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Identifying Predictive Bacterial Markers from Cervical Swab Microbiota on Pregnancy Outcome in Woman Undergoing Assisted Reproductive Technologies.

Authors:  Annacandida Villani; Andrea Fontana; Stefano Barone; Silvia de Stefani; Mariangela Primiterra; Massimiliano Copetti; Concetta Panebianco; Cristiana Parri; Natale Sciannamè; Pasqua Anna Quitadamo; Alessandra Tiezzi; Liliana Santana; Annamaria Maglione; Federica D'Amato; Francesco Perri; Simone Palini; Valerio Pazienza
Journal:  J Clin Med       Date:  2022-01-28       Impact factor: 4.241

2.  Association of the eukaryotic vaginal virome with prophylactic antibiotic exposure and reproductive outcomes in a subfertile population undergoing in vitro fertilisation: a prospective exploratory study.

Authors:  A M Eskew; M J Stout; B S Bedrick; J K Riley; K R Omurtag; P T Jimenez; R R Odem; V S Ratts; S L Keller; E S Jungheim; K M Wylie
Journal:  BJOG       Date:  2019-10-20       Impact factor: 6.531

3.  Association between bacterial vaginosis and fecundability in Kenyan women planning pregnancies: a prospective preconception cohort study.

Authors:  Erica M Lokken; Lisa E Manhart; John Kinuthia; James P Hughes; Clayton Jisuvei; Khamis Mwinyikai; Charles H Muller; Kishor Mandaliya; Walter Jaoko; R Scott McClelland
Journal:  Hum Reprod       Date:  2021-04-20       Impact factor: 6.918

4.  Cultivable vaginal Lactobacillus is not associated with fecundability in Kenyan women attempting to conceive.

Authors:  Erica M Lokken; Clayton Jisuvei; James P Hughes; Kishor Mandaliya; Lisa E Manhart; Khamis Mwinyikai; Charles H Muller; Walter Jaoko; John Kinuthia; R Scott McClelland
Journal:  Fertil Steril       Date:  2022-01-17       Impact factor: 7.329

Review 5.  The Impact of Female Genital Microbiota on Fertility and Assisted Reproductive Treatments.

Authors:  Pedro Brandão; Manuel Gonçalves-Henriques
Journal:  J Family Reprod Health       Date:  2020-09

6.  Antibacterial and Antifungal Activity of the Human Endometrial Fluid during the Natural Cycle.

Authors:  Marta Bregón-Villahoz; Maria-Dolores Moragues; Inés Arrieta-Aguirre; Mikel Azkargorta; Lucía Lainz; Miren Diez-Zapirain; Maria Iglesias; Maria-Begoña Prieto; Ana Matorras; Antonia Exposito; Felix Elortza; Roberto Matorras
Journal:  Infect Dis Obstet Gynecol       Date:  2021-06-16

Review 7.  Gut and vaginal microbiomes on steroids: implications for women's health.

Authors:  Madeline E Graham; William G Herbert; Stephanie D Song; Harshini N Raman; Jade E Zhu; Paulina E Gonzalez; Marina R S Walther-António; Marc J Tetel
Journal:  Trends Endocrinol Metab       Date:  2021-05-25       Impact factor: 10.586

8.  Alterations in Vaginal Microbiota and Associated Metabolome in Women with Recurrent Implantation Failure.

Authors:  Min Fu; Xiaowei Zhang; Yiheng Liang; Shouren Lin; Weiping Qian; Shangrong Fan
Journal:  mBio       Date:  2020-06-02       Impact factor: 7.867

9.  Effect of clindamycin and a live biotherapeutic on the reproductive outcomes of IVF patients with abnormal vaginal microbiota: protocol for a double-blind, placebo-controlled multicentre trial.

Authors:  Thor Haahr; Nina La Cour Freiesleben; Anja Pinborg; Henriette Svarre Nielsen; Vibeke Hartvig; Anne-Lis Mikkelsen; Thomas Parks; Niels Uldbjerg; Jørgen Skov Jensen; Peter Humaidan
Journal:  BMJ Open       Date:  2020-10-13       Impact factor: 2.692

10.  Characterization of the Vaginal DNA Virome in Health and Dysbiosis.

Authors:  Rasmus Riemer Jakobsen; Thor Haahr; Peter Humaidan; Jørgen Skov Jensen; Witold Piotr Kot; Josue Leonardo Castro-Mejia; Ling Deng; Thomas Dyrmann Leser; Dennis Sandris Nielsen
Journal:  Viruses       Date:  2020-10-09       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.